Amphix Bio raised $12.5M in Seed funding. Nick Sather and Samuel Stupp Amphix Bio spun Amphix out of Northwestern University to develop supramolecular peptide therapeutics that repair spinal cord injuries and regenerate neural tissue. When discipline meets timing, regeneration stops being theory.
Let’s keep the conversation going on LinkedIn: (http://linkedin.com/in/jesselandry23) Tech ecosystem lives here 👉 http://devcuration.com Work with me here 👉 www.jesselandry.com